Management of alemtuzumab-induced Graves’ disease in pregnancy: a case report and literature review
The present case adds to the limited literature on ALZ-induced GD in pregnancy, providing further insight into the variability of disease onset, progression, and neonatal outcomes. It underscores the importance of close monitoring and a multidisciplinary approach to ensure optimal maternal and fetal health.
Authors
- Marsida Teliti (ORCID: https://orcid.org/0009-0007-4606-8923)
- Pietro Costa
- Spyridon Chytiris (ORCID: https://orcid.org/0000-0002-7999-3505)
- Mario Rotondi
- Flavia Magri
- Maria Gallo
Institutions
- University of Pavia (IT)
- Istituti Clinici Scientifici Maugeri (IT)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.3389/fimmu.2025.1722459
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47